Brief: Australian Clinical Labs Sees FY26 Revenue A$735M - A$745M
15/02/2026 21:15
Feb 16 (Reuters) - Australian Clinical Labs Ltd ACL.AX: SEES FY26 REVENUE A$735M - A$745M SEES FY26 UNDERLYING EBIT A$66M - A$69M Further company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million